首页> 外文OA文献 >Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer

【2h】

Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer

机译：aDEBaR试验中的毒性分析：顺序蒽环类 - 紫杉烷治疗与FEC120治疗高风险乳腺癌的辅助治疗比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
S. Karger Gmbh; Ulrich Andergassend; Svjetlana Mohrmanna; Jessica Salmena; Thomas Zwingersi; Marion Kiechlec; Nadja Harbecke; Klaus Friesed; E Wolfgang Jannia Brigitte Rackd; Mammakarzinom Taxan; Anthrazyklin Toxizität;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 每周一次的紫杉烷–蒽环类联合方案与3周一次的以蒽环类为基础方案治疗r局部晚期乳腺癌的随机对照研究 [J] . Qiu-Wen Tan, Ting Luo, Hong Zheng, 癌症（英文版） . 2018,第002期
2. Toxicity analysis in the ADEBAR trial: Sequential anthracycline-taxane therapy compared with FEC120 for the adjuvant treatment of high-risk breast cancer [J] . Sch?nherrA., Aivazova-FuchsV., AnneckeK., Breast care . 2012,第4期

机译：ADEBAR试验中的毒性分析：蒽环类-紫杉烷类序贯治疗与FEC120的比较对高危乳腺癌的辅助治疗
3. Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer [J] . Alexandra Sch?nherr, Viktoria Aivazova-Fuchs, Katja Annecke, Breast care . 2012,第4期

机译：ADEBAR试验中的毒性分析：蒽环类-紫杉类序贯疗法与FEC120的比较对高危乳腺癌的辅助治疗
4. Acute toxicity of intensity-modulated radiotherapy with simultaneous integrated boost compared to 3D-conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer - interim results from a randomized controlled trial [J] . Krug D., Koeder C., Haefner M. F., Strahlentherapie und Onkologie . 2016,第Suppla1期

机译：强度调节放疗的急性毒性与乳腺癌辅助治疗中的3D-on成形放疗相比同时集成升压与乳腺癌的佐剂治疗 - 来自随机对照试验的中期结果
5. Italian Breast Cancer Adjuvant Chemo-hormone Therapy Cooperative Group Trials [C] . F. Boccardo, A. Rubagotti, D. Amoroso, International Conference on "Adjuvant Therapy of Primary Breast Cancer" . 1998

机译：意大利乳腺癌辅助化疗化学 - 激素治疗合作团体试验
6. The Use and Enhancement of Anti-Cancer Vaccine Therapy with Low-Toxicity Drugs for the Treatment of HER2 Positive Breast Cancer [D] . Oechsle, Crystal Mae 2019

机译：低毒药物抗癌疫苗治疗在HER2阳性乳腺癌治疗中的应用和增强
7. Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer [O] . Alexandra Schönherr, Viktoria Aivazova-Fuchs, Katja Annecke, 2012

机译：ADEBAR试验中的毒性分析：蒽环类-紫杉类序贯疗法与FEC120的比较对高危乳腺癌的辅助治疗
8. Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer [O] . Schönherr Alexandra, Aivazova-Fuchs Viktoria, Annecke Katja, 2012

机译：aDEBaR试验中的毒性分析：顺序蒽环类 - 紫杉烷治疗与FEC120治疗高风险乳腺癌的辅助治疗比较

Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅